Are you Dr. Rosenberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 111 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1611 NW 12th Ave
Miami, FL 33136Phone+1 305-585-6303Fax+1 305-689-5899
Summary
- Dr. Andrew Rosenberg, MD is a board certified pathologist in Miami, Florida. He is currently licensed to practice medicine in Florida, Massachusetts, and Maine. He is affiliated with Jackson Health System, UMHC-Sylvester Comprehensive Cancer Center, and University of Miami Hospital.
Education & Training
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1981 - 1986
- Lewis Katz School of Medicine at Temple UniversityClass of 1981
Certifications & Licensure
- FL State Medical License 2010 - 2026
- MA State Medical License 1984 - 2013
- ME State Medical License Active through 1989
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Boston Magazine Castle Connolly, 2010-2011
Publications & Presentations
PubMed
- 127 citationsClinical and Biochemical Manifestations of Hyaluronidase DeficiencyMarvin R. Natowicz, M. Priscilla Short, Yu Wang, G. Richard Dickersin, Mark C. Gebhardt
The New England Journal of Medicine. 1996-10-03 - 120 citationsAngiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institutionVaia Florou, Andrew E. Rosenberg, Eric D. Wieder, Krishna V. Komanduri, Despina Kolonias
Journal for Immunotherapy of Cancer. 2019-08-08 - 231 citationsAxitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.Breelyn A. Wilky, Matteo Trucco, Ty K. Subhawong, Vaia Florou, Wungki Park
The Lancet. Oncology. 2019-06-01
Press Mentions
- Horowitz Solitary Fibrous Tumor Initiative Inspired by Patient’s, Physician’s Shared PassionJune 9th, 2023